NUK - logo

Search results

Basic search    Expert search   

Currently you are NOT authorised to access e-resources NUK. For full access, REGISTER.

2 3 4 5 6
hits: 140
31.
  • COVID‐19 Pandemic Effects o... COVID‐19 Pandemic Effects on Breast Cancer Diagnosis in Croatia: A Population‐ and Registry‐Based Study
    Vrdoljak, Eduard; Balja, Melita Perić; Marušić, Zlatko ... The oncologist (Dayton, Ohio), July 2021, Volume: 26, Issue: 7
    Journal Article
    Peer reviewed
    Open access

    Background Our objective was to assess the effects of COVID‐19 antiepidemic measures and subsequent changes in the function of the health care system on the number of newly diagnosed breast cancers ...
Full text

PDF
32.
  • Impact of the number of the... Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia
    Bišof, Vesna; Katić, Andrija; Soče, Majana ... Neoplasma, 04/2024, Volume: 71, Issue: 2
    Journal Article
    Peer reviewed
    Open access

    The aim of the study was to conduct a retrospective database analysis to understand the current treatment patterns and outcomes to plan potential improvements in therapy delivery and patient ...
Full text
33.
  • Predictors of outcome in elderly patients with metastatic colorectal cancer: the final results of a prospective phase II study of bevacizumab in combination with capecitabine as first-line treatment
    Omrčen, Tomislav; Katić, Andrija; Tomić, Snježana ... Anti-cancer drugs, 06/2020, Volume: 31, Issue: 5
    Journal Article
    Peer reviewed

    In 2011, we demonstrated that bevacizumab in combination with capecitabine as first-line treatment is effective in elderly patients with metastatic colorectal cancer (mCRC). We present the final ...
Check availability
34.
  • A phase 3 trial evaluating ... A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer
    Kim, Tae Won; Elme, Anneli; Kusic, Zvonko ... British journal of cancer, 2016-Nov-08, 20161108, Volume: 115, Issue: 10
    Journal Article
    Peer reviewed
    Open access

    We assessed the treatment effect of panitumumab plus best supportive care (BSC) vs BSC on overall survival (OS) in patients with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer ...
Full text

PDF
35.
  • The relevance of macrocytosis induction during neoadjuvant dose-dense chemotherapy in breast cancer patients
    Boraska Jelavić, Tihana; Podrug, Mario; Ban, Marija ... Anti-cancer drugs, 01/2022, Volume: 33, Issue: 1
    Journal Article
    Peer reviewed

    The aim of this study was to explore the red blood cell changes that occur during neoadjuvant dose-dense chemotherapy (NAC) of breast cancer. Also, we investigated the role of macrocytosis as a ...
Check availability
36.
  • Is macrocytosis a potential biomarker of the efficacy of dose-dense paclitaxel-carboplatin combination therapy in patients with epithelial ovarian cancer?
    Boraska Jelavić, Tihana; Boban, Toni; Brčić, Luka ... Anti-cancer drugs, 2017-September, Volume: 28, Issue: 8
    Journal Article
    Peer reviewed

    The aims of this study were to investigate a clinical observation that patients with epithelial ovarian cancer treated with first-line platinum-paclitaxel chemotherapy combination (TP) develop ...
Check availability
37.
  • Expenditures on Oncology Dr... Expenditures on Oncology Drugs and Cancer Mortality‐to‐Incidence Ratio in Central and Eastern Europe
    Vrdoljak, Eduard; Bodoky, Gyorgy; Jassem, Jacek ... The oncologist (Dayton, Ohio), January 2019, Volume: 24, Issue: 1
    Journal Article
    Peer reviewed
    Open access

    Background There is a steady decline in cancer mortality in Western Europe (WE), but this trend is not so obvious in Central and Eastern Europe (CEE). One of the largest discrepancies between WE and ...
Full text

PDF
38.
  • Adjuvant Chemotherapy in Locally Advanced Cervical Cancer After Treatment with Concomitant Chemoradiotherapy--Room for Improvement?
    Jelavić, Tihana Boraska; Miše, Branka Petrić; Strikic, Ante ... Anticancer research 35, Issue: 7
    Journal Article
    Peer reviewed

    The standard treatment for locally advanced cervical cancer (LACC) is concomitant chemoradiotherapy. In the majority of patients with LACC after properly executed concomitant chemoradiotherapy local ...
Check availability
39.
  • High‐throughput molecular a... High‐throughput molecular assays for inclusion in personalised oncology trials – State‐of‐the‐art and beyond
    Edsjö, Anders; Russnes, Hege G.; Lehtiö, Janne ... Journal of internal medicine, June 2024, Volume: 295, Issue: 6
    Journal Article
    Peer reviewed
    Open access

    In the last decades, the development of high‐throughput molecular assays has revolutionised cancer diagnostics, paving the way for the concept of personalised cancer medicine. This progress has been ...
Full text
40.
  • Chemobrachyradiotherapy and... Chemobrachyradiotherapy and consolidation chemotherapy in treatment of locally advanced cervical cancer
    Tomić, Krešimir; Berić Jozić, Gordana; Parić, Ana ... Wiener Klinische Wochenschrift, 11/2021, Volume: 133, Issue: 21-22
    Journal Article
    Peer reviewed

    Summary Background Given the lack of primary and secondary prevention programs and cancer awareness in general, cervical cancer remains one of the main causes of cancer-related death in developing ...
Full text
2 3 4 5 6
hits: 140

Load filters